179 related articles for article (PubMed ID: 10096531)
1. The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study.
Pascual M; Vallhonrat H; Cosimi AB; Tolkoff-Rubin N; Colvin RB; Delmonico FL; Ko DS; Schoenfeld DA; Williams WW
Transplantation; 1999 Mar; 67(5):737-41. PubMed ID: 10096531
[TBL] [Abstract][Full Text] [Related]
2. Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis.
Al-Awwa IA; Hariharan S; First MR
Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S15-8. PubMed ID: 9631859
[TBL] [Abstract][Full Text] [Related]
3. Modifying cyclosporine associated renal allograft dysfunction.
Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
[TBL] [Abstract][Full Text] [Related]
4. Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies.
Abrass CK; Berfield AK; Stehman-Breen C; Alpers CE; Davis CL
Am J Kidney Dis; 1999 Jan; 33(1):11-20. PubMed ID: 9915262
[TBL] [Abstract][Full Text] [Related]
5. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
Solez K; Vincenti F; Filo RS
Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
[TBL] [Abstract][Full Text] [Related]
7. The importance of renal biopsy in the management of renal transplantation.
Veisa G; Bîrlescu CA; Siriopol D
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):376-80. PubMed ID: 25076703
[TBL] [Abstract][Full Text] [Related]
8. Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy.
Bakker RC; Hollander AA; Mallat MJ; Bruijn JA; Paul LC; de Fijter JW
Kidney Int; 2003 Sep; 64(3):1027-34. PubMed ID: 12911553
[TBL] [Abstract][Full Text] [Related]
9. The utility of 6-month protocol renal biopsy under modern immunosuppression.
Yango A; Gohh R; Wang LJ; Morrissey P; Shih M; Lowery K; Charpentier K; Gautam A; Mendonca C; Kumar S; Dworkin L; Monaco A
Clin Nephrol; 2008 Dec; 70(6):490-5. PubMed ID: 19049705
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic contribution of renal allograft biopsies at various intervals after transplantation.
Kon SP; Templar J; Dodd SM; Rudge CJ; Raftery MJ
Transplantation; 1997 Feb; 63(4):547-50. PubMed ID: 9047149
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
12. ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiences.
Stock KF; Klein BS; Cong MT; Regenbogen C; Kemmner S; Büttner M; Wagenpfeil S; Matevossian E; Renders L; Heemann U; Küchle C
Clin Hemorheol Microcirc; 2011; 49(1-4):527-35. PubMed ID: 22214724
[TBL] [Abstract][Full Text] [Related]
13. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
14. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
[TBL] [Abstract][Full Text] [Related]
15. Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Ruiz JC; Campistol JM; Mota A; Prats D; Gutiérrez JA; Castro A; García J; Morales JM; Grynió JM; Gómez JM; Arias M
Transplant Proc; 2003 Aug; 35(5):1669-70. PubMed ID: 12962750
[TBL] [Abstract][Full Text] [Related]
16. Etiology of Early Renal Allograft Dysfunction and Comparison between Dysfunction and Function Group: A Single Center Study.
Hadiuzzaman KM; Islam SF; Faroque MO; Hossain RM; Munirunnessa M; Selim SI; Morshed M
Mymensingh Med J; 2017 Oct; 26(4):748-755. PubMed ID: 29208861
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
18. Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection.
Brown FG; Nikolic-Paterson DJ; Chadban SJ; Dowling J; Jose M; Metz CN; Bucala R; Atkins RC
Transplantation; 2001 Jun; 71(12):1777-83. PubMed ID: 11455258
[TBL] [Abstract][Full Text] [Related]
19. [Blood levels of cyclosporine, acute rejections and the prognosis of the allografts in pediatric renal allograft recipients].
Sakuma T; Ogawa O; Kawamura T; Hasegawa A; Kamidono S
Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1450-9. PubMed ID: 7474634
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
